Literature DB >> 18548259

Crohn's disease in Tuzla region of Bosnia and Herzegovina: a 12-year study (1995-2006).

Nada Pavlovic-Calic1, Nermin N Salkic, Adnan Gegic, Midhat Smajic, Ervin Alibegovic.   

Abstract

BACKGROUND: Bosnia and Herzegovina (B&H) is one of the Eastern European countries with lacking data on Crohn's disease (CD) epidemiology. GOAL: We aimed to assess incidence of CD in Tuzla Canton of B&H during a 12-year period (1995-2006).
METHODS: We retrospectively evaluated hospital records of both CD inpatients and outpatients residing in Tuzla Canton of B&H (total of 496,280 inhabitants) between 1995 and 2006. Patient that satisfied previously described criteria were included in the study. Incidence rates were calculated with age standardisation using European standard population. Trends in incidence were evaluated as moving 3-year averages.
RESULTS: During the observed period, 140 patients met the diagnostic criteria for CD. Mean annual incidence was found to be 2.3/10(5) (95% CI=1.6-3.0) inhabitants ranging from 0.20 to 6.45 per 10(5). Mean annual crude incidence during the last 5 years of study (2002-2006) was 4.15/10(5) (95% CI=3.35-4.95). The prevalence of CD, at the end of the observed period was found to be 28.2/10(5) (95% CI=23.5-32.9). CD incidence increased dramatically from 0.27/10(5) in 1995-1997 to 4.84/10(5) in 2004-2006, as well as did the number of colonoscopies performed; from 29 in 1995 to 850 in 2006. We observed almost constant trend of around three new cases of CD per 100 colonoscopies performed.
CONCLUSIONS: (1)Our area is the region of moderate incidence of CD with the trend that remains toward continuing increase in the rates of CD, which is most likely a direct consequence of the growing number of performed colonoscopies. (2) We believe that in the future years, CD incidence in our region will probably further increase and stabilise at a level of around five cases per 10(5) inhabitants.

Entities:  

Mesh:

Year:  2008        PMID: 18548259     DOI: 10.1007/s00384-008-0493-1

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  23 in total

Review 1.  Crohn's disease.

Authors:  Fergus Shanahan
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

Review 2.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

3.  Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001.

Authors:  Laszlo Lakatos; Gabor Mester; Zsuzsanna Erdelyi; Mihaly Balogh; Istvan Szipocs; Gyorgy Kamaras; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

Review 4.  Is it time to re-classify Crohn's disease?

Authors:  Richard N Fedorak
Journal:  Best Pract Res Clin Gastroenterol       Date:  2004       Impact factor: 3.043

Review 5.  Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe?

Authors:  L Lakatos; P L Lakatos
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

6.  Summarizing indices for comparison of cancer incidence data.

Authors:  R Doll; P Cook
Journal:  Int J Cancer       Date:  1967-05-15       Impact factor: 7.396

7.  Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).

Authors:  S Shivananda; J Lennard-Jones; R Logan; N Fear; A Price; L Carpenter; M van Blankenstein
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

8.  The changing epidemiology of inflammatory bowel diseases.

Authors:  A Lapidus
Journal:  Acta Gastroenterol Belg       Date:  2001 Apr-Jun       Impact factor: 1.316

9.  Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival.

Authors:  E V Loftus; M D Silverstein; W J Sandborn; W J Tremaine; W S Harmsen; A R Zinsmeister
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

10.  Change in incidence of Crohn's disease and ulcerative colitis in Denmark. A study based on the National Registry of Patients, 1981-1992.

Authors:  K Fonager; H T Sørensen; J Olsen
Journal:  Int J Epidemiol       Date:  1997-10       Impact factor: 7.196

View more
  9 in total

Review 1.  Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn's disease--review of the literature.

Authors:  Andreas G Wibmer; Anton J Kroesen; Jörn Gröne; Heinz-Johannes Buhr; Joerg-Peter Ritz
Journal:  Int J Colorectal Dis       Date:  2010-07-14       Impact factor: 2.571

Review 2.  The global burden of IBD: from 2015 to 2025.

Authors:  Gilaad G Kaplan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

3.  NOD2/CARD15 mutations in Polish and Bosnian populations with and without Crohn's disease: prevalence and genotype-phenotype analysis.

Authors:  Nermin N Salkic; Grazyna Adler; Iwona Zawada; Ervin Alibegovic; Beata Karakiewicz; Anna Kozlowska-Wiechowska; Michał Wasilewicz; Violetta Sulzyc-Bielicka; Dariusz Bielicki
Journal:  Bosn J Basic Med Sci       Date:  2015-05-25       Impact factor: 3.363

4.  Disease burden of inflammatory bowel disease in China from 1990 to 2017: Findings from the global burden of diseases 2017.

Authors:  Yan Qiu; Wen Ren; Ying Liu; Wei-Er Chen; Xiao-Hua Pan; Jing-Jing Ren
Journal:  EClinicalMedicine       Date:  2020-09-20

5.  Circulating cytokines reflect mucosal inflammatory status in patients with Crohn's disease.

Authors:  Farid Ljuca; Adnan Gegic; Nermin N Salkic; Nada Pavlovic-Calic
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

Review 6.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases.

Authors:  Glinda S Cooper; Milele L K Bynum; Emily C Somers
Journal:  J Autoimmun       Date:  2009-10-09       Impact factor: 7.094

7.  Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity.

Authors:  Claudia Sardu; Eleonora Cocco; Alessandra Mereu; Roberta Massa; Alessandro Cuccu; Maria Giovanna Marrosu; Paolo Contu
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

8.  Inflammatory bowel disease in Tuzla Canton, Bosnia-Herzegovina: A prospective 10-year follow-up.

Authors:  Emir Tulumović; Nermin Salkić; Denijal Tulumović
Journal:  World J Gastroenterol       Date:  2021-05-28       Impact factor: 5.742

9.  Prevalence of Anal Fistulas in Europe: Systematic Literature Reviews and Population-Based Database Analysis.

Authors:  Damián García-Olmo; Gert Van Assche; Ignacio Tagarro; Mary Carmen Diez; Marie Paule Richard; Javaria Mona Khalid; Marc van Dijk; Dimitri Bennett; Suvi R K Hokkanen; Julián Panés
Journal:  Adv Ther       Date:  2019-10-26       Impact factor: 3.845

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.